Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Revenue

Anika Therapeutics had revenue of $29.61M in the quarter ending March 31, 2026, with 13.16% growth. This brings the company's revenue in the last twelve months to $116.26M, up 36.52% year-over-year. In the year 2025, Anika Therapeutics had annual revenue of $112.82M, down -5.91%.

• Revenue (ttm): $116.26M
• Revenue Growth: +36.52%
• P/S Ratio: 1.67
• Revenue / Employee: $494,736
• Employees: 235
• Market Cap: 201.58M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	112.82M	-7.09M	-5.91%
Dec 31, 2024	119.91M	-885.00K	-0.73%
Dec 31, 2023	120.79M	6.97M	6.12%
Dec 31, 2022	113.83M	-33.97M	-22.98%
Dec 31, 2021	147.79M	17.34M	13.29%
Dec 31, 2020	130.46M	15.85M	13.83%
Dec 31, 2019	114.61M	9.06M	8.58%
Dec 31, 2018	105.56M	-7.87M	-6.93%
Dec 31, 2017	113.42M	10.04M	9.71%
Dec 31, 2016	103.38M	10.38M	11.16%
Dec 31, 2015	93.00M	-12.60M	-11.93%
Dec 31, 2014	105.60M	30.51M	40.64%
Dec 31, 2013	75.08M	3.72M	5.22%
Dec 31, 2012	71.36M	6.58M	10.16%
Dec 31, 2011	64.78M	9.22M	16.60%
Dec 31, 2010	55.56M	15.42M	38.42%
Dec 31, 2009	40.14M	4.36M	12.17%
Dec 31, 2008	35.78M	4.95M	16.06%
Dec 31, 2007	30.83M	3.99M	14.86%
Dec 31, 2006	26.84M	-2.99M	-10.04%
Dec 31, 2005	29.83M	-	-

Data Source: Fiscal.ai Last updated: Apr 29, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error